Mast Cells as an Indicator and Prognostic Marker in Molecular Subtypes of Breast Cancer

被引:26
作者
Carpenco, Ecaterina [1 ,2 ]
Ceausu, Raluca Amalia [3 ,4 ]
Cimpean, Anca Maria [3 ,4 ]
Gaje, Pusa Nela [3 ,4 ]
Saptefrati, Lilian [1 ]
Fulga, Veaceslav [1 ,2 ]
David, Valeriu [1 ,2 ]
Raica, Marius [3 ,4 ]
机构
[1] Nicolae Testemitanu State Univ Med & Pharm, Dept Histol Cytol & Embryol, Kishinev, Moldova
[2] Nicolae Testemitanu State Univ Med & Pharm, Lab Morphol, Kishinev, Moldova
[3] Victor Babes Univ Med & Pharm, Dept Microscop Morphol Histol, Timisoara, Romania
[4] Victor Babes Univ Med & Pharm, Angiogenesis Res Ctr Timisoara, Timisoara, Romania
来源
IN VIVO | 2019年 / 33卷 / 03期
关键词
Breast cancer; hormone receptors; mast cell; prognosis; tryptase; tumor grade; ESTROGEN; TRYPTASE;
D O I
10.21873/invivo.11534
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background/Aim: Mast cells (MCs) represent the most controversial non-malignant element of the tumor microenvironment. Our aim was to study how MCs density and distribution (intratumoral-MCit versus peritumoral-MCpt) relate to tumor grade and molecular subtypes. Materials and Methods: MCs tryptase immunohistochemistry was performed on 80 cases of breast carcinomas. Results: For Luminal A tumors, a partial correlation was detected between MCit and progesterone receptor (PR) (p=0.005). Luminal B tumors showed a significant correlation between MCpt and age (p=0.009), estrogen receptor (ER) (p=0.017) and PR (p=0.035). MCit and MCpt were strongly interrelated in this subtype (p=0.002) and in triple-negative breast cancers (p=0.002). In HER2 subtype, MCpt tumors were significantly correlated with HER2 (p=0.044). In G2 tumors, MCpt correlated with ER (p=0.015) and PR (p=0.038) while in G3 tumors ER correlated with both MCit (p=0.009) and MCpt (p=0.000487) tumors. Conclusion: MCs dynamics are strongly influenced by hormone receptors and HER2 status. MCit increased in aggressive tumor types and is a worse prognostic factor.
引用
收藏
页码:743 / 748
页数:6
相关论文
共 25 条
[1]  
Allred DC, 1998, MODERN PATHOL, V11, P155
[2]  
[Anonymous], ANTICANCER RES
[3]  
[Anonymous], ONCOTARGET
[4]  
Austin David, 2018, Oncotarget, V9, P33912, DOI 10.18632/oncotarget.26089
[5]   Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer [J].
Bense, Rico D. ;
Sotiriou, Christos ;
Piccart-Gebhart, Martine J. ;
Haanen, John B. A. G. ;
van Vugt, Marcel A. T. M. ;
de Vries, Elisabeth G. E. ;
Schroeder, Carolien P. ;
Fehrmann, Rudolf S. N. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (01)
[6]   Mast cells in breast cancer angiogenesis [J].
Cimpean, Anca Maria ;
Tamma, Roberto ;
Ruggieri, Simona ;
Nico, Beatrice ;
Toma, Alina ;
Ribatti, Domenico .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 115 :23-26
[7]  
De Leo Bianca, 2017, F1000Res, V6, P667, DOI 10.12688/f1000research.11432.1
[8]  
Della Rovere F, 2007, ANTICANCER RES, V27, P2465
[9]  
Ehrlich P., 1879, ARCH ANAT PHYSIOL, V3, P166
[10]   The relationship between breast cancer molecular subtypes and mast cell populations in tumor microenvironment [J].
Glajcar, Anna ;
Szpor, Joanna ;
Pacek, Agnieszka ;
Tyrak, Katarzyna Ewa ;
Chan, Florence ;
Streb, Joanna ;
Hodorowicz-Zaniewska, Diana ;
Okon, Krzysztof .
VIRCHOWS ARCHIV, 2017, 470 (05) :505-515